Literature DB >> 3907952

Giant cell arteritis and polymyalgia rheumatica.

G G Hunder, C J Michet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907952

Source DB:  PubMed          Journal:  Clin Rheum Dis        ISSN: 0307-742X


× No keyword cloud information.
  7 in total

1.  Giant cell vasculitis is a T cell-dependent disease.

Authors:  A Brack; A Geisler; V M Martinez-Taboada; B R Younge; J J Goronzy; C M Weyand
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

2.  Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.

Authors:  J Font; R Cervera; A Lopez-Soto; L Pallares; X Bosch; S Ampurdanes; F J Casals; M Ingelmo
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

Review 3.  Spectrum of giant cell vasculitis.

Authors:  N Mohan; G Kerr
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

4.  Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology.

Authors:  A D Wagner; J Björnsson; G B Bartley; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

Review 5.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

6.  Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients.

Authors:  J C Mertens; G Willemsen; J L Van Saase; J H Bolk; B A Dijkmans
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

7.  Late-onset systemic lupus erythematosus presenting as polymyalgia rheumatica.

Authors:  M Maragou; F Siotsiou; H Sfondouris; Z Nicolia; G Vayopoulos; P Dantis
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.